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Abstract
For many years, oxidative thiol modifications in cytosolic proteins were largely disregarded as in vitro artifacts,
and considered unlikely to play significant roles within the reducing environment of the cell. Recent develop-
ments in in vivo thiol trapping technology combined with mass spectrometric analysis have now provided
convincing evidence that thiol-based redox switches are used as molecular tools in many proteins to regulate
their activity in response to reactive oxygen and nitrogen species. Reversible oxidative thiol modifications have
been found to modulate the function of proteins involved in many different pathways, starting from gene
transcription, translation and protein folding, to metabolism, signal transduction, and ultimately apoptosis. This
review will focus on three well-characterized eukaryotic proteins that use thiol-based redox switches to influence
gene transcription, metabolism, and signal transduction. The transcription factor Yap1p is a good illustration of
how oxidative modifications affect the function of a protein without changing its activity. We use glyeraldehyde-
3-phosphate dehydrogenase to demonstrate how thiol modification of an active site cysteine re-routes metabolic
pathways and converts a metabolic enzyme into a pro-apoptotic factor. Finally, we introduce the redox-sensitive
protein tyrosine phosphatase PTP1B to illustrate that reversibility is one of the fundamental aspects of redox-
regulation. Antioxid. Redox Signal. 11, 997–1014.
Reactive Oxygen Species and Oxidative Stress
Reactive oxygen species (ROS) include a broad vari-ety of different chemical oxidants, including hydrogen
peroxide (H2O2), superoxide anion (O2), singlet oxygen
(1O2), and hydroxyl radicals (OH). Inside the cells, reactive
oxygen species are constantly generated as side products of
neutrophil-mediated phagocytosis (46), cellular respiration
(20), and various NADPH oxidases (131). This ROS produc-
tion appears not to be just a harmful byproduct of aerobic
metabolism, but seems to involve a tightly regulated process
(41). It allows low levels of ROS to serve as important signaling
molecules in processes such as gene transcription, protein ty-
rosine de- and phosphorylation, stress protection, apoptosis,
and metabolism (29, 41, 118, 128). Similarly, reactive nitrogen
oxide species (RNS), which include the free radical nitric oxide
(NO), peroxynitrite (ONOO–), and nitrogen dioxide (NO2),
also play significant roles as redox active molecules (89). In the
presence of oxygen, endogenously produced NO can rapidly
lead to S-nitrosation of protein thiols (SNO) and glutathione
(GSNO), presumably via the formation of other reactive ni-
trogen oxide species, such as N2O3, NO2, and thiyl radicals
(116). Over 200 different proteins have been found to be tar-
geted by S-nitrosation, including metabolic enzymes, phos-
phatases, transcription factors, and others (48).
To maintain redox homeostasis under conditions where
ROS and RNS concentrations begin to increase (see below),
cells can draw on a wide arsenal of enzymatic and nonenzy-
matic defense and repair strategies. For rapid ROS detox-
ification and scavenging, most cells use a combination of
antioxidant enzymes with very high catalytic activity, such as
superoxide dismutase (SOD), catalase (CAT), and glutathione
peroxidase (Gpx), or of high cellular abundance, such as
peroxiredoxins (>0.5% of total cell protein) (107). The original
oxidation status of cytosolic protein thiols is maintained and
rapidly restored by the action of two redox- balancing sys-
tems, thioredoxin (Trx) and glutaredoxin (Grx), which draw
their reducing power ultimately from NADPH (49). The
overall reducing environment of the cytosol of 230 to
260 mV, which represents the cellular standard redox po-
tential, is preserved by the equilibrium between the small
tripeptide glutathione (GSH) and its oxidized form (GSSG)
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(58, 63). The GSH=GSSG couple constitutes the redox buffer of
most eukaryotic and prokaryotic cells. The low reactivity of
the GSH thiol at physiological conditions (pKa of 9.4) (133)
is counterbalanced by its high intracellular concentration
(*1–10 mM) and rapid enzymatic regeneration by glutathi-
one reductase and NADPH (15).
Once ROS and RNS concentrations exceed the antioxidant
capacity of the cell, oxidative damage to DNA, lipids, and
proteins can occur. This puts organisms into a state defined as
oxidative stress (125). It triggers a highly conserved response
in both prokaryotic and eukaryotic cells (42). The response
includes increased expression of oxidant scavengers, chaper-
ones, proteases, and DNA repair enzymes to mitigate and
reverse oxidative damage on proteins and DNA. Severe oxi-
dative damage, that will eventually lead to apoptosis and cell
death, has been shown to accompany many pathological
conditions, such as cancer, neurodegenerative diseases, and
diabetes (25, 80). Moreover, it is the damaging effect of in-
creasing oxidant concentrations that is thought to be the un-
derlying culprit of eukaryotic aging (41).
Cysteine Thiols–Central Components
of Redox-Sensitive Nanoswitches
Cysteine residues play important roles in the biochemistry
of many proteins due to the unique chemical properties of
their side chain. The high reactivity, redox properties, and
ability of thiol groups to coordinate metal ions designate
cysteines as the amino acids of choice to form key catalytic
components of enzymes (10). Over the past 10 years, how-
ever, a new role for cysteine thiols emerged. They form the
central building block of thiol-based redox switches in redox-
regulated proteins. Redox-sensitive cysteines undergo revers-
ible thiol modifications in response to reactive oxygen or
nitrogen oxide species, thereby modulating protein function,
activity, or localization. They play important roles in many
signal transduction cascades (e.g., PTEN and PTP1B) (74, 150),
gene transcription (e.g., p53) (102), as well as in the immediate
defense against oxidative stress conditions (e.g., Hsp33, Hsf-1)
(2, 52).
What makes cysteine residues particularly redox-sensitive
and proteins potentially redox-regulated? Regulatory thiol
modifications involve one or more cysteines, whose reactivity
is largely determined by the cysteine’s structural environment
and its pKa value. Most cytoplasmic protein thiols have pKa
values of greater than 8.0, which render the thiol groups
predominantly protonated and largely nonreactive at intra-
cellular pH (43). Thiol groups of redox-sensitive cysteines, on
the other hand, have characteristically much lower pKa val-
ues, ranging from as low as *3.5 in thiol transferase to *5.1–
5.6 in protein tyrosine phosphatases. Under physiological pH
conditions, these thiols are therefore present as deprotonated,
highly reactive thiolate anions (RS-) (78, 81). The low pKa
values of redox-sensitive cysteines arise primarily from sta-
bilizing charge–charge interactions between the thiolate anion
and neighboring positively charged or aromatic side chains
(106, 152).
Thiolate anions, in contrast to their protonated counter-
parts, are highly susceptible to oxidation by ROS and RNS
and can undergo a diverse spectrum of oxidative modifica-
tions (141). These include sulfenic (SOH), sulfinic (SO2H),
and sulfonic (SO3H) acids, disulfide bonds (PrSSPr), or ni-
trosothiols (SNO) (27, 128, 129) (Fig. 1). Cysteine sulfenic acids
and their deprotonated cysteine-sulfenates are remarkably
reactive and versatile oxidation products, which are fre-
quently formed (Fig. 1) first upon reaction of protein thiols
with H2O2 (112). Due to their high reactivity, sulfenic acids are
often considered as metastable intermediates that undergo
FIG. 1. Oxidative thiol modifica-
tions. Oxidation of cysteine thiol
groups by H2O2 leads to sulfenic
acid (R-SOH) formation. Sulfenic
acids are either stabilized by nearby
charges or react with neighboring
thiols or proximal nitrogen to form
disulfide bonds (R0-S-S-R@) or sulfe-
namide bonds (R0-S-NH-R0), respec-
tively. In the presence of high H2O2
concentrations, overoxidation to
sulfinic (R-SO2H) or sulfonic acid
(R-SO3H) occurs. Although a few
protein-specific sulfinic acid reduc-
tases have been identified, overoxi-
dation is still considered to be largely
irreversible in vivo. Alternatively, re-
action of thiolate anions (RS-) with
oxidized cysteines of other proteins or
low molecular weight thiols such as
glutathione (GSSG) leads to mixed
disulfide bond formation (R0-S-S-R@)
or S-glutathionylation (R-S-SG), respectively. Overoxidation of disulfide bonds in the presence of strong oxidants can
cause thiosulfinate (R0-SO-S-R@) or irreversible thiosulfonate (R0-SO2-S-R@) formation. Most oxidative thiol modifications
are reduced by members of the glutaredoxin (Grx) system and thioredoxin (Trx) system (reductants), which draw their
reducing power from cellular NADPH. Exposure of thiolate anions to reactive nitrogen oxide species causes S-nitrosothiol
formation, whereas treatment with peroxynitrite yields S-nitrothiol formation. The exact mechanism by which individual
RNS cause oxidative thiol modifications in vivo is still under investigation.
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further reactions to form stable modifications, such as dis-
ulfides with other protein thiols or S-glutathionylation with
the small redox buffer component glutathione (27, 112, 128,
129). Importantly, most oxidative thiol modifications are fully
reversible in vivo and utilize dedicated oxidoreductases, such
as the thioredoxin or glutaredoxin system, to quickly restore
the original redox state upon the cell’s return to nonstress
conditions (26, 30, 119) (Fig. 1). It appears that it is the reaction
rate with these dedicated oxidoreductases that often deter-
mines the lifespan of oxidized proteins and supports their
accumulation even in an overall reducing environment (7, 77).
Extended and=or extensive exposure of proteins to oxi-
dants can lead to the ‘‘overoxidation’’ of cysteine residues to
form sulfinic and sulfonic acids (82). These oxidative modifi-
cations are considered largely irreversible in vivo, although a
small number of protein-specific sulfinic acid reductases (e.g.,
sulfiredoxin, sestrin) have recently been identified (16, 142).
Moreover, strong oxidative stress conditions often result in
excessive disulfide bonding, protein misfolding, aggrega-
tion, and degradation, and will eventually lead to cell death
(28, 127).
The type and extent of oxidative modifications in redox-
regulated proteins depends on the specific type of oxidant
(75), its absolute level and persistency, the subcellular location
of oxidant production and its distance to the target protein
(29, 41). Even small changes in the basal level of intracellular
ROS and RNS can cause oxidative modifications in proteins
that are specifically sensitive to these oxidants. Oxidative thiol
modifications most often lead to changes in the structure of
proteins and cause either their activation (e.g., OxyR, Hsp33)
(52, 99) or inactivation (e.g., PTEN, GapDH) (120, 150). With
the help of innovative in vivo and in vitro thiol trapping
techniques (reviewed in refs. 72 and 149) and global redox
proteomic methods (reviewed in ref. 76), the number of redox-
regulated proteins that have been identified is steadily in-
creasing (3, 27, 59). Redox-regulated proteins turn out to be
involved in nearly every physiological process, including
metabolism, signaling, cell growth, gene expression, tran-
scription factor activation, differentiation, senescence, and
apoptosis (41, 118, 128, 129). Interestingly, more often than
not, redox-regulated proteins appear to be central compo-
nents of these pathways, suggesting that protein redox reg-
ulation is the cell’s fundamental strategy to fine-tune cellular
processes in response to ROS and RNS. Here, we focus on a
subset of proteins with thiol-based redox switches, whose
redox regulation influences distinct processes in eukaryotic
cells: transcription, metabolism, and signal transduction.
Changing Gene Transcription to Protect
Cells Against Oxidative Stress
The ability to rapidly adapt gene expression to environ-
mental changes is crucial for the growth and survival of every
organism. Over the past few years, an increasing number
of transcription factors have been shown to be directly regu-
lated by accumulating ROS (59). These include the activator
protein-1 (AP-1), NF-kB, Myb, p53, USF (upstream stimula-
tory factor), NF-1 (nuclear factor 1), and others (9, 87, 101).
Redox regulation of these proteins is mediated by the modi-
fication of one or more cysteine residues, which causes either
the activation (e.g., AP-1, NF-kB) or inactivation (e.g., USF) of
the respective transcription factor (87, 101).
We focus here primarily on AP-1-like transcription factors,
which are well- characterized leucine-zipper (bZIP) DNA-
binding proteins, that are implicated in the regulation of
multiple cellular processes, including proliferation, differen-
tiation, stress response, and apoptosis (55, 61,134). In Sac-
charomyces cerevisiae, the AP-1-like transcription factor Yap1p
plays an important role in the cellular response to oxidative
stress and various xenobiotics (8, 68, 93). The Yap1p regulon
includes as many as 70 genes encoding most of yeast’s anti-
oxidant enzymes and components of the cellular thiol-
reducing pathway, including Trx, Grx, GPx, SOD, and CAT
(22, 54, 68).
Yap1—Changing the Redox State
Means Switching Homes
The activation of Yap1p upon peroxide stress (i.e., H2O2) is
triggered by highly conserved cysteine residues, which are
reduced under nonstress conditions and rapidly form in-
tramolecular disulfide bonds upon exposure to oxidative
stress conditions (31, 143). The redox-active cysteines in Yap1p
are clustered in two cysteine-rich domains (CRD) (Fig. 2).
Each CRD contains three cysteines (Cys303, Cys310, and
Cys315) positioned in the n-CRD at the center of the protein,
and three cysteines (Cys598, Cys620, and Cys629) located in
the c-CRD at the C-terminus of Yap1p. Embedded in the c-
CRD is also a leucine-rich nuclear export signal (NES), which
is directly responsible for Yap1p’s subcellular distribution and
indirectly responsible for its functional regulation (69, 147).
Yap1p’s function as a transcription factor is controlled by
redox-regulated changes in the accessibility of the NES (69,
70). In nonstressed yeast cells, the NES is exposed and Yap1p
shuttles between the nucleus and the cytosol. Upon migration
into the nucleus, Yap1p is rapidly exported in a process that is
mediated by binding to the nuclear export receptor Crm1
(also called Xpo1) (70, 147). The outcome is a relatively low
nuclear level of Yap1p and therefore a low constitutive ac-
tivity in unstressed yeast cells. Exposure of yeast cells to H2O2,
however, leads to rapid redox-mediated conformational
changes in Yap1p, that disrupt the interaction with Crm1.
This, in turn, leads to the nuclear accumulation of Yap1p and
results in significantly increased antioxidant gene transcrip-
tion (31, 69).
Yap1p—Member of a Two-Component Redox Relay
Over the past few years it became evident that Yap1p is not
directly oxidized by H2O2 but functions in a two-component
system with its partner protein glutathione peroxidase Gpx3
(also named Orp1), a protein originally identified as a hy-
droperoxide scavenger (54). Upon exposure to H2O2, the
catalytic site cysteine Cys36 of Gpx3 attacks the O–O bond of
the substrate, thereby forming a sulfenic acid (Cys36-SOH) at
its active site cysteine (81) (Fig. 2). Cys36-SOH subsequently
reacts with Cys598 of Yap1p’s c-CRD to form a mixed Yap1p-
Gpx3 disulfide intermediate. Rearrangement of this disulfide
by intramolecular thiol-disulfide exchange with Cys303 of
Yap1p then leads to the formation of the first inter-domain
disulfide bond between Cys303-Cys598 in Yap1 and the re-
generation of reduced Gpx3 (32, 81). Triggered by this inter-
domain disulfide bond formation, Yap1p undergoes further
conformational changes that apparently mask the NES
and disrupt the Yap1p–Crm1 interaction (31, 96) (Fig. 2)
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Subsequently, additional disulfide bonds between cysteines
of n-CRD and c-CRD of Yap1p form (see below) presumably
in a similar Gpx3-mediated process (29). Upon return to
nonstress conditions, the disulfide bonds are reduced by the
thioredoxin-system, leading to the reversal of the structural
rearrangements and to the re-exposure of NES (31). Thus,
Crm1-mediated nuclear export of Yap1p can resume and
Yap1’s transcriptional activity returns to its low pre-stress
levels (143).
A similar relay system has also been described for the
redox-regulation of the mammalian AP-1 transcription factor
that is formed upon dimerization of c-Fos and c-Jun. In con-
trast to Yap1p, however, which requires the sulfenic acid in
Gpx3 for its oxidative activation, mammalian AP-1 uses the
reduced cysteines of the redox factor Ref-1 for its reductive
activation (139, 145). In the c-Fos=c-Jun AP-1 transcription fac-
tor, a single conserved cysteine residue in the DNA-binding
domains of each of the two individual proteins appears to
form the molecular redox switch (1). In vitro treatment of AP-1
with alkylating agents, such as N-ethylmaleimide (NEM) has
been shown to cause a decrease in transcriptional activity
while exposure to reductants, such as DTT, or mutation of the
cysteines results in enhanced DNA binding (1, 97). Once ox-
idized and inactivated, AP-1 cannot be directly reduced and
activated by thioredoxin (Trx) (1). Activation of AP-1 requires
Ref-1, which appears to draw its electrons from thioredoxin
and ultimately from NADPH (146).
Redox-Mediated Fine-Tuning of Yap1p’s
Functional Activity
In vitro studies demonstrated that Yap1p’s activation by
H2O2 involves a multistep formation of three inter-domain
disulfide bonds. This finding led to a model suggesting that
all six cysteine residues in Yap1p are important for optimal
H2O2 sensing and signal transduction (96). Transcriptional
activity of Yap1p appears to be directly determined by the
balance between Gpx3-mediated disulfide bond formation
in Yap1p, which is regulated by intracellular H2O2 levels,
and thioredoxin-mediated disulfide bond reduction, which is
regulated by intracellular NADPH levels (32), suggesting that
the cellular ratio of H2O2 to NADPH ultimately determines
the number of disulfide bonds that form and the level of Yap1
activity (96).
In vitro activation generates at least three oxidation forms of
Yap1p, which differ in the number of disulfide bonds (96). As
mentioned above, formation of the Cys303–Cys598 disulfide
bond seems to initiate the activation of Yap1p by directly
causing conformational changes that bury the NES. Forma-
tion of the second inter-domain disulfide bond between
Cys310 and Cys629 appears to further increase Yap1p’s
transcriptional activity. Both inter-domain disulfide bonds
seem to be required for the recruitment of Rox3p to the TRX2
promoter, a prerequisite for maximum Yap1p-mediated
TRX2 expression (45). Moreover, Yap1p mutant strains car-
rying substitutions at either Cys310 or Cys629 show a mixture
of oxidized and reduced Yap1p species upon H2O2 stress in
vivo. This result suggests that the formation of the Cys310–
Cys629 bond stabilizes the Cys303–Cys598 disulfide and
prevents its premature reduction (143). The arrangement of
the third disulfide bond between Cys315 and Cys620 appears
to be important for maintaining Yap1p in the nucleus and
upholding its activity in the later stages of the H2O2 re-
sponse (96).
Noteworthy at this point is the observation that a third
protein appears to be involved in peroxide-induced Yap1p
oxidation. In vivo studies showed that the protein Ybp1 forms
an H2O2-induced complex with the c-CRD-containing region
of Yap1p, thereby stimulating nuclear accumulation and ac-
tivity of the transcription factor (137). Although Ybp1 has
several cysteine residues, this interaction appears to be based
on a nonredox function of Ybp1 (29). Because Dybp1=Dgpx3
double mutants show very similar effects on the regulation of
Yap1p’s activity as the individual single mutants, a model
was proposed in which Ybp1 and Gpx3 act in the same
pathway (137) (Fig. 2). The H2O2 stress-induced stimulation of
the Yap1p–Ybp1 complex formation, together with the cyto-
plasmic localization of Ybp1, suggests that the molecular
function of Ybp1 might be important for disulfide bond for-
mation or signal transduction between Gpx3 and Yap1p (95,
137). Alternatively, Ybp1 might function as mediator in the
formation of the Gpx3–Yap1p disulfide intermediate or in
preventing Gpx’s sulfenic acid intermediate from reacting
with its own second cysteine, which would short-cut the ox-
idation relay.
Activation of Yap1p—More Than
One Way to Get the Response
In contrast to the activation of Yap1p in response to ROS,
such as peroxide, which depends on Gpx3 and=or Ybp1, ac-
tivation of Yap1p in response to diamide, electrophiles, and
FIG. 2. Model of the Yap1p-Gpx3 redox relay. Under nonstress conditions, the cysteines of Yap1, which are clustered in
two cysteine-rich domains (n-CRD, c-CRD), are reduced. (1) The nuclear export sequence (NES) of Yap1p is accessible for
interaction with Crm1, and Yap1p shuttles between the cytosol and the nucleus. It prevents Yap1p’s nuclear accumulation
and guarantees low constitutive activity under nonstress conditions. (2) Upon exposure of yeast cells to oxidative stress
conditions (i.e., H2O2) the active site cysteine (Cys36) of glutathione peroxidase Gpx3 attacks the O–O bond of H2O2, thereby
forming a sulfenic acid at the active site cysteine. At the same time, Ybp1 binds to Yap1p. (3) In the next step, the active site
sulfenic acid of Gpx reacts with Cys598 of Yap1p, causing the formation of a Gpx3-Yap1p disulfide intermediate. (4) A
thiolate anion formed at Cys303 of Yap1p attacks the intermolecular disulfide bond, thereby causing the formation of the
inter-domain Cys303–Cys598 disulfide bond and the recovery of reduced Gpx3. (5) Additional inter-domain disulfide bonds
form in a process likely also involving Gpx3. While formation of the Cys310–Cys629 appears to increase transcriptional
activation, (6) formation of Cys315–Cys620 might prolong the H2O2-mediated signal. The exact role of Ybp1 has yet to be
determined, but it appears that Ybp1 mediates the redox signal from Gpx3 to Yap1p. (7) Disulfide bond formation appears to
lead to conformational changes in Yap1p, which mask the NES and prevent nuclear export. Yap1p accumulates in the nucleus
and activates the oxidative stress response. For reasons of simplicity, only one oxidized form of Yap1p is shown in the
nucleus.
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divalent heavy metal cations appears to function indepen-
dently of Gpx3 and does not involve any inter-domain di-
sulfide bonds (8, 31). In the presence of diamide, thiol
modification of the three cysteines in c-CRD seems sufficient
to disrupt interaction between Yap1p and Crm1 and to pro-
mote the nuclear accumulation of Yap1p (67). Diamide-me-
diated thiol modifications might either lead to the formation
of an intra-domain disulfide bond between two of the three
cysteines in c-CRD (67) or cause individual cysteine modifi-
cation, such as the formation of sulfenylhydrazine (8, 31, 67).
Activation of Yap1p without disulfide bond formation was
also observed in response to the superoxide generator and
alkylating agent menadione and N-ethylmaleimide under
anaerobic conditions as well as in a Dgpx3 strain (8). Based on
these findings, it is likely that other non-ROS inducers of
Yap1p, such as cadmium or selenate, activate Yap1p by either
binding to or chemically modifying individual C-terminal
cysteines (8, 31). This type of activation is similar to the die-
thylmaleate-mediated activation of the Yap1 homologue Pap1
in Saccharomyces pombe, which is suggested to operate through
covalent cysteine adduct formation (23).
Yap1p—A Prototype for Emerging
Concepts in Redox Regulation?
Yap1p’s mechanism of activation combines a number
of features that have become increasingly common among
redox-regulated proteins. One concept that emerges is that
redox-regulated disulfide bond formation causes extensive
conformational changes in the affected proteins, which either
lead to the folding of previously unfolded regions (e.g.,
Yap1p, Pap1) (23, 143) or to the unfolding of previously folded
regions (e.g., Hsp33, RsrA) (52, 98). Whether disulfide bond
formation mediates folding or unfolding of the protein de-
pends largely on the individual protein, its function, and the
mechanism of regulation. Interestingly, it appears not to
correlate with the final activity of the oxidized protein. Di-
sulfide bond formation in Yap1p, for instance, converts a
poorly folded region into a compactly folded protein domain
in a process that effectively buries the NES and activates the
transcriptional response (143). In contrast, ROS-mediated
disulfide bond formation in the redox-regulated chaperone
Hsp33 causes large portions of the protein to adopt a natively
unfolded protein conformation (52). This unfolding is crucial
for the exposure of a substrate-binding site in Hsp33, which is
capable of binding proteins that undergo stress-induced un-
folding and protects bacteria against oxidative damage (52).
In the anti-sigma factor RsrA, on the other hand, disulfide-
mediated unfolding abolishes its binding to the sigma factor,
which is released and induces antioxidant gene transcription
in Streptomyces coelicolor (98). Extensive biophysical studies on
other redox-regulated proteins will reveal how many redox-
regulated proteins use this rapid and fully reversible mecha-
nism to translate changes in their redox state into functional
changes.
A second mechanistic aspect that might turn into a new
paradigm is that thiol- based regulatory switches such as
found in Yap1p or the related Pap1p do not function as pri-
mary ROS sensors. Instead, both redox-regulated transcrip-
tion factors use peroxidases as ROS sensors, which relay the
redox signal from their active site cysteine to the acceptor
protein and trigger disulfide bond formation (138). It is con-
ceivable that other thiol peroxidases serve as central relay
stations for yet to be identified redox-regulated proteins
in vivo.
Redox Theme With Variations—The Nrf2-Keap1
Connection
In multicellular organisms, protection against ROS, nitric
oxide, heavy metals, and electrophilic compounds is primar-
ily mediated by the redox-sensitive Nrf2-Keap1 signaling
pathway (35, 65). Nrf2, the nuclear factor erythroid-2 related
factor, functions as master transcription factor. It forms het-
erodimers with other transcription factors such as c-Jun, Jun B,
Jun D, ATF3, and ATF4, thereby regulating the transcription
of >200 eukaryotic genes. The gene products are involved in
cellular protection against oxidative stress, in detoxification of
electrophiles, and in proteasomal activity (65).
Under nonstress conditions, Nrf2 forms a tight complex
with the redox-sensitive stress receptor protein Keap1 (Kelch-
like ECH-associated protein-1). Keap1 functions as a negative
regulator of Nrf2 by retaining the transcription factor in the
cytoplasm and targeting it for ubiquitin-mediated proteaso-
mal degradation (64). Keap1 facilitates Nrf2’s proteasomal
degradation by acting as a substrate adaptor protein for
Cul-containing E3 ubiquitin ligases, which catalyze the ubi-
quitination and subsequent proteasomal degradation of Nrf2
(reviewed in ref. 151). Exposure of cells to ROS or other in-
ducers, however, promotes the escape of Nrf2 and its subse-
quent translocation into the nucleus, where it activates the
antioxidant response element (ARE) (94).
Stress sensing is mediated by the cysteine-rich protein
Keap1. At least three (Cys151, Cys273, Cys288) of the 25 to 27
cysteines present in mammalian Keap1 appear to play critical
roles. Interestingly, any type of thiol modifications at these
three cysteine residues seem to be sufficient to induce con-
formational rearrangements in Keap1, which abrogate its
binding to Nrf2 and activate the oxidative stress response (65).
Recently, Keap1 was identified as a metal-binding protein,
which binds zinc in a 1:1 stochiometry (35). Mutant studies
suggested that two of the three redox-sensitive cysteines
(Cys273 and Cys288) are directly involved in zinc coordina-
tion under reducing nonstress conditions (35). Exposure to
ROS was found to induce disulfide bond formation and lead
to zinc release and conformational rearrangements in Keap1,
suggesting that Keap1 senses ROS via a redox-sensitive zinc
center. This model is very reminiscent of the redox-regulated
anti-sigma factor RsrA (98) and the bacterial chaperone Hsp33
(52). Both proteins use redox-sensitive zinc-centers as ROS-
sensors and undergo dramatic conformational changes upon
disulfide bond formation and zinc release. The additional
layers of regulation that are involved in the Nrf2-Keap1 sig-
naling pathway have been expertly reviewed in the past (151),
and their discussion goes beyond the scope of this review.
GapDH—Putting Cellular Metabolism
Under Redox-Control
A variety of key metabolic enzymes in eukaryotic cells have
been identified to contain redox sensitive active site cysteine
residues, which become oxidatively modified upon exposure
to ROS and=or RNS. These redox-regulated metabolic en-
zymes include among others carbonic anhydrase, creatine
kinase (CK ), and glyeraldehyde-3-phosphate dehydrogenase
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(GapDH) (62, 88, 105). Here, we focus on GapDH, which has a
central function in glycolysis in both prokaryotic and eu-
karyotic cells. Glycolysis is the almost universal central path-
way of glucose catabolism and represents the main source of
metabolic energy for many cells and organisms. GapDH cat-
alyzes the reversible oxidative phosphorylation of glyer-
aldehyde-3-phosphate (GAP) to 1,3-bisphosphoglycerate in
the presence of nicotinamide adenine dinucleotide and inor-
ganic phosphate. It uses a highly conserved and reactive active
site cysteine (Cys149 or Cys150, respectively) for the initial
nucleophilic attack on the aldehyde of GAP (18). This active
site cysteine has been shown to be highly sensitive to oxidative
modifications by a variety of different reactive oxygen and
nitrogen oxide species. In addition, GapDH appears to play an
important role in a plethora of other processes that are unre-
lated to its glycolytic function (126). These include transcrip-
tion (153), regulation of Ca2þ-homeostasis (100), membrane
fusion, microtubule bundling, phosphotransferase activity,
nuclear RNA export, and DNA replication and repair (24,
126). Recent studies have furthermore shown an active role of
GapDH in apoptosis (47) and an involvement in Huntington’s
(117), Parkinson’s (135), and Alzheimer’s disease (83). The
proapoptotic role of GapDH in these diseases seems to be
dependent upon its nuclear accumulation and its formation of
insoluble aggregates (28, 114).
GapDH functions as a homotetramer. Each subunit con-
tains one active site cysteine and a second, somewhat less
conserved cysteine three amino acids apart. Upon exposure to
oxidative stress conditions, the active-site thiolate in GapDH
was shown to rapidly become the target of both reversible
and irreversible thiol modifications, whose nature largely
depends on the type and concentration of oxidants. In the
presence of H2O2, for instance, GapDH’s active site cysteine
was found to be oxidized to either sulfenic, sulfinic, sulfonic
acid, or engaged in an intramolecular disulfide bond with the
neighboring Cys154 (75). Incubation with HNO (nitroxyl
anion) or the NO-donor DEA=NO (diethylamine NONOate),
on the other hand, was shown to cause S-nitrosation (47, 88),
S-glutathionylation (26, 88, 120), carbonylation (21), and ADP-
ribosylation (34). All these modifications cause the reversible
or irreversible inhibition of GapDH enzyme activity and lead
to the attenuation of glycolysis in vivo.
Re-Routing the Metabolic Flux to Protect
Cells Against Oxidative Damage
Oxidative stress-induced inhibition of GapDH as a central
component of glycolysis leads to the rapid re-routing of
glucose-6-phosphate into the pentose phosphate pathway
(PPP). This serves as immediate response to protect against
oxidative insults (44, 104) (Fig. 3). The PPP is one of the key
routes for nicotinamide adenine dinucleotide phosphate
(NADPH) production in the eukaryotic cytoplasm. The prod-
uct NADPH serves as electron donor for both glutathione
reductase (Grx) and thioredoxin reductase (TrxR), and is there-
fore essential to restore and maintain the reducing envi-
ronment of the cytosol (6). Oxidative inactivation of triose
phosphate isomerase (TPI) causes a similar re-direction of the
metabolic flux from glycolysis to PPP. TPI, which directly
precedes GapDH in glycolysis, catalyzes the isomerization of
dihydroxyacetone phosphate to GAP. Yeast cells with re-
duced TPI activity are highly resistant to treatment with the
oxidant diamide (103), supporting the model that re-routing
the glucose flux maintains the cytoplasmic NADPH=NADPþ
equilibrium and counteracts oxidative stress. When cells re-
turn to nonstress conditions, reduced glutathione and thior-
edoxin (77) rapidly restore GapDH activity and therefore the
fine-tuned metabolic flux of glucose.
These findings show that ROS-mediated changes in the
activity of glycolytic enzymes trigger important and imme-
diate response mechanisms that control the redox state of the
cell and protect cells against increased oxidative damage.
These observations also form the basis for discussions that
inhibitors of glycolysis such as 2-deoxy-D-glucose (71) might
serve as potential therapeutics for oxidative stress-related
neuronal disorders such as Alzheimer’s disease and Parkin-
son’s disease (104).
ROS-Mediated GapDH Aggregation
and Its Role in Apoptosis
Both nitrosative and oxidative stress conditions have been
shown to lead to intermolecular disulfide bond formation
between GapDH subunits, causing extensive GapDH oligo-
merization both in vitro and in vivo (28, 92) (Fig. 3). Interest-
ingly, these aggregates were very similar in their characteristic
features (e.g., Congo red staining) to amyloid-like fibrils pre-
viously reported for a-synuclein (66) and ß-amyloid (14). The
ability of thiol reductants such as dithiothreitol (DTT) to dis-
solve these aggregates was dependent on the extent of oxi-
dation, supporting the model that intermolecular disulfide
bonds are involved in aggregate formation. Two cysteines
appear to play the major role in this oxidative stress-induced
aggregation process, the active site cysteine (Cys149 in rabbit
GapDH, Cys150 in yeast GapDH) and, to a lesser extent,
Cys281 (28, 92). The precise mechanism by which these large
disulfide-linked GapDH oligomers form has yet to be deter-
mined. Given that the active site cysteine is located at the
bottom of GapDH’s catalytic site, the distance between these
cysteines on the individual subunits is too far to allow inter-
subunit disulfide bond formation to occur (92). It is conceiv-
able, however, that initial thiol modification of Cys150 causes
extensive conformational changes that lead to the exposure of
additional cysteines such as Cys281 and allow them to un-
dergo intermolecular disulfide bond formation (92).
Importantly, in vivo studies demonstrated that the degree
of GapDH aggregation correlates well with the rate of oxi-
dative stress-induced cell death (92). These results sug-
gested that insoluble GapDH aggregates are either cytotoxic
per se, or promote apoptosis indirectly by interacting with
other intracellular aggregate-prone proteins, such as tau or
a-synuclein (91, 110) (Fig. 3). This mechanism appears to
contradict an earlier model proposed by Hara et al. in which
NO-induced alterations of the GapDH=Siah1 signaling cas-
cade were thought to cause the GapDH-dependent cell death
under nitrosative stress conditions (47) (Fig. 3). According to
this model, S-nitrosation of Cys150 in GapDH of HEK293 cells
stimulates the interaction between the ATP-dependent E3-
ubiquitin ligase Siah1, and Lys225 in GapDH (47, 50). Siah1,
which possesses a nuclear localization signal (NLS), escorts
GapDH into the nucleus where the association between
GapDH and Siah1 appears to stabilize the E3-ligase (47).
Stabilization of Siah1, in turn, increases the rate of degra-
dation for a set of different target proteins and ultimately
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triggers apoptosis (109) (Fig. 3). As so often in biology, it is
more than likely that both mechanisms are linked to oxidative
stress-induced cell death. More research is required to identify
whether the two mechanisms work synergistically or inde-
pendently, and to elucidate whether oxidant specificity of
GapDH’s active site cysteine determines the apoptotic route
that cells take (47). In either case, these studies demonstrate
that GapDH, a protein best known for its central role in gly-
colysis, probably plays an equally important role as a redox-
regulated proapoptotic protein (47, 92).
Role of GapDH’s Redox-Regulation in Signaling
Nuclear translocation of GapDH mediated by oxidative
modifications of its active site cysteine appears to correlate
with the initiation of cell death and the physiology of a
number of neurodegenerative diseases (28, 47, 114, 135). In
addition, GapDH translocation might also play a role in in-
tracellular signaling (24, 47). GapDH has long been shown to
associate with DNA (108), and translocation into the nucleus
might further stimulate this interaction. It is conceivable that
oxidative stress-mediated nuclear translocation of GapDH
serves as mediator for relaying extranuclear stress signals
into the nucleus, which would translate changes in the cel-
lular redox state directly into changes in transcriptional ac-
tivity (122). This is in line with data that show the direct
involvement of metabolic enzymes or homologs such as
GapDH or CtBP in transcription (121, 153). P38, a nuclear
form of GapDH, was found to be a key component of OCA-S,
a multicomponent Oct-1 co- activator complex, which is es-
FIG. 3. Oxidative thiol modifications of GapDH—From cytoprotection to cytotoxicity. (A) ROS-mediated inhibition of
GapDH re-routes metabolic flux as immediate defense against oxidative insult. Oxidative stress-induced inhibition of GapDH
as a central component of glycolysis leads to the rapid re-routing of glucose-6-phosphate into the pentose phosphate pathway
(PPP), one of the key routes for NADPH production in the eukaryotic cytoplasm. NADPH serves as electron donor for
glutathione reductase and thioredoxin reductase, and is therefore essential to restore and maintain the reducing environment
of the cytosol. (B) Model of GapDH=Siah1-signaling cascade-dependent cell death. Exposure of GapDH to RNS causes
S-nitrosation of Cys150 in GapDH. S-nitrosation stimulates the interaction between the E3-ubiquitin ligase Siah1 and GapDH.
Siah1, which possesses a nuclear localization signal (NLS), escorts GapDH into the nucleus where the association between
GapDH and Siah1 appears to stabilize the E3-ligase. This stabilization, in turn, increases the rate of degradation for a set of
different target proteins, and ultimately triggers cell death. (C) Model of apoptosis triggered by ROS-mediated GapDH
aggregation. Exposure of GapDH to excess ROS leads to the initial disulfide bond formation between either Cys150 and
Cys154 (intramolecular disulfide bond) or between two active site cysteines Cys150. The latter leads to extensive confor-
mational changes and exposes additional cysteines (e.g., Cys281) that undergo further intermolecular disulfide bond for-
mation. This results in the accumulation of insoluble aggregates composed of multiple GapDH subunits in the cytosol and the
nucleus. The aggregates are either intrinsically cytotoxic or interact with other aggregation-prone proteins (e.g., Aß, tau,
a-synuclein) to cause cytotoxicity. For reasons of simplicity, only one subunit of the GapDH tetramer is shown.
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sential for S phase-dependent histone H2B transcription
during DNA replication (153). GapDH’s direct interaction
with the promoter-bound Oct-1 supports the binding of the
OCA-S complex to Oct-1. Noteworthy, both the interaction of
GapDH with Oct-1 as well as the transcriptional activity of
OCA-S are altered by the NADþ=NADH redox status (153).
This NADþ=NADH influence might link the metabolic
and=or redox state of the cell to histone transcription and
DNA replication. However, the structural basis for NADþ=
NADH modulation and the mechanism by which GapDH
supports gene transcription have yet to be determined (153).
Very recently, the involvement of GapDH’s redox regula-
tion in a multistep phosphorelay signaling in Schizosacchar-
omyces pombe was reported (90). In phosphorelays, which are
variations of the bacterial two-component signaling system, a
histidine-containing phosphotransfer (HPt) protein mediates
the phosphotransfer from a sensor kinase to a response reg-
ulator, which in turn activates a kinase cascade and eventu-
ally causes induction of the corresponding response genes
(111). In Schizosaccharomyces pombe, osmotic and oxidative
stress conditions activate the mitogen-activated protein ki-
nase (MAPK ) Spc1 (124) (Fig. 4). Activated Spc1 phosphor-
ylates the Atf1 transcription factor, which induces several
stress response genes, including ctt1þ encoding for cyto-
plasmic catalase (140). The transmission of the stress signals to
Spc1 in S. pombe occurs via a multistep phosphorelay system
consisting of the phosphotransfer protein Mpr1 and the re-
sponse regulator Mcs4, which forms a complex with the
stress-responsive Wis4=Win1 MAP kinase kinase kinase
(MAPKKK ) (5). Morigasaki et al. showed that the Msc4-
MAPKKK complex contains Tdh1, an isoform of GapDH (90).
Oxidative modification of Tdh1’s active site cysteine Cys152
was found to result in enhanced binding between Tdh1 and
Msc4, which appears to be essential for the interaction be-
tween Msc4 and Mpr1 and promotes the transmission of H2O2
stimuli to the downstream components of the MAP-kinase
cascade (i.e., Wis1, Spc1) (5) (Fig. 4). Mutation of the active site
cysteine (C152S) or deletion of the tdh1 gene was demon-
strated to cause a decrease in Msc4 and Mpr1 interaction,
resulting in a defect in H2O2-signaling through the phos-
phorelay. These results reveal that peroxide-induced oxida-
tive modification of the redox-sensitive cysteine in GapDH
plays a key role in transmitting H2O2 stimuli to a response
regulator, which is part of a multistep phosphorelay cascade,
thereby modulating cellular signaling (90). As GapDH is
conserved in multiple eukaryotic organisms, GapDH might
play an important role in other signaling relay systems in
different species.
GapDH—One of Many Redox-Regulated
Metabolic Enzymes
GapDH is only one of many metabolic enzymes whose
activity is regulated by oxidative thiol modifications (155).
FIG. 4. Role of redox regulation by GapDH in
stress signaling. In the fission yeast Schizosacchar-
omyces pombe, a multistep phosphorelay composed
of the sensor kinase Mak2=Mak3, the histidine-
containing phosphotransferase (HPt) Mpr1 and the
Msc4 response regulator transmit stress signals, such
as H2O2, to the Spc1 MAPK cascade. This cascade
is composed of the Wis4=Win1 MAPKKKs, the
MAPKK Wis1, and Spc1 MAPK as final receptor.
Wis4=Win1 and Msc4 form a complex with the
GapDH isoform Tdh1. H2O2-mediated oxidative
modification of Tdh1’s active site cysteine Cys152
enhances the interaction between Tdh1 and the Msc4
response regulator, which, in turn, promotes the in-
teraction and phosphorelay signaling between the
response regulator Msc4 and the HPt protein Mpr1.
This interaction is required for the transmission of
the H2O2 stress signal to Spc1.
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Creatine kinase, for instance, which plays a central role in
controlling cellular energy homeostasis in energy demanding
tissues such as muscle and brain, contains one highly oxi-
dation-sensitive active site cysteine Cys283 (105). ROS and
RNS-mediated thiol modification of Cys283 leads to the re-
versible inactivation of creatine kinase, which appears to af-
fect muscle performance and Ca2þ homeostasis (130). This
inactivation seems to be of particular importance during
oxidative stress conditions encountered in ischemia, cardio-
myopathy, and several neurodegenerative disorders (re-
viewed in ref. 115). Similarly, both glycogen synthase and
protein phosphatase-I are readily inactivated upon treatment
with oxidized glutathione (38, 123). This inactivation might
explain the high glycogenolytic activity that has been ob-
served in liver tissue treated with thiol oxidants (115). Car-
bonic anhydrase 3, which maintains pH homeostasis in
mammals, has been found to be sensitive to oxidative mod-
ifications of Cys186 and Cys181 (62). Although earlier results
suggested already a role of carbonic anhydrase 3 in the
cellular response to oxidative stress (19), it remains to be
determined whether these observed oxidative thiol modifi-
cations are involved. Interestingly, for many of these en-
zymes, oxidative modifications such as S-glutathionylation
have been considered to be a protective measure rather than a
redox-regulatory feature, with the purpose to protect active
site cysteines against irreversible overoxidation and inacti-
vation (30, 32). However, because loss of enzyme activity is
inevitably connected with these oxidative thiol modifications
and rapid reactivation is usually achieved upon return to
reducing nonstress conditions, this argument might be purely
semantic.
Redox Regulation of Eukaryotic
Signal Transduction Cascades
Reversible protein tyrosine phosphorylation and dephos-
phorylation are important posttranslational protein modi-
fications involved in a variety of cellular signal transduction
cascades that control metabolism, motility, cell growth, pro-
liferation, differentiation, and survival (4, 11). Whereas phos-
phorylation reactions are carried out by specific tyrosine
kinases, dephosphorylation reactions are catalyzed by mem-
bers of a large superfamily of protein tyrosine phosphatases
(PTPs). In the human genome, 107 PTP encoding genes have
been identified (4). Even though members of the PTP super-
family show only low sequence similarities and possess dif-
ferent topologies (12, 39), they are all characterized by an
active site cysteine located within a highly conserved 11-
residue motif [I=V]HCXXGXXR[S=T]. This active site cysteine
exhibits a very low pKa value [*5.6 in PTP1B, *4.7 in YOP
phosphatase (78, 152)]. It is present as a thiolate anion at
physiological pH, which renders the catalytic site cysteine
highly reactive and promotes its nucleophilic attack at a
phosphotyrosine (pTyr) substrate (11, 40). This reaction re-
sults in the formation of a covalent phospho-cysteine inter-
mediate, which is subsequently hydrolyzed by an activated
water molecule (33). The very same properties that make
PTP’s active site cysteine such an excellent nucleophile, also
makes it highly susceptible to oxidants such as H2O2 and
superoxide, and make the proteins highly sensitive to oxida-
tive stress-mediated inactivation (33). By regulating tyrosine
phosphorylation- dependent signaling events using redox-
mediated posttranslational modification of PTP activity, ROS
can actively function as second messenger (33, 106).
PTP1B—Using Cyclic Sulfenamide
Formation as Redox Switch
PTP1B, a prototypic member of the PTP family, is widely
expressed in multiple cell types and tissues including brain,
liver, and skeletal muscle (36). It is considered to be the
physiological regulator of glucose homeostasis via its control
of leptin sensitivity and its function as a major negative reg-
ulator of the insulin pathway (36, 37). Furthermore, PTP1B
appears to have oncogenic properties in various cancer types
such as in colon cancer, where it activates Src by catalyzing the
dephosphorylation of the negative regulator residue Tyr530
(154).
In active PTP1B, the catalytic cysteine Cys215 is reduced
and located at the base of a cleft that lies within the pTyr
substrate binding pocket (11, 12) (Fig. 5). Oxidation of Cys215
in the presence of mild oxidative conditions, such as 100mM
H2O2, causes the reversible formation of a cyclic sulfenamide
species (Fig. 6). This oxidation is accompanied by major
changes in the structure of the active site and leads to the
inhibition of enzyme activity (112, 136). The generation of a
cyclic sulfenamide bond in PTP1B probably occurs through
the initial oxidation of Cys215 to a sulfenic acid intermediate.
This step is followed by a nucleophilic attack of the backbone
nitrogen atom of Ser216 on the sulfenated Cys215 forming
cyclic sulfenamide and concomitantly releasing water (112,
136). Amino acids in the active site of PTP1B, such as the
highly conserved His214, facilitate the cyclization by pro-
viding steric and=or electrostatic effects (112) (Fig. 5).
Upon formation of the active site sulfenamide, PTP1B
undergoes dramatic tertiary structural rearrangements at
its catalytic site (Fig. 5). These involve conformational re-
arrangements of both PTP and pTyr loops, which are central
to catalysis and substrate recognition. In addition, converting
the PTP loop into an open conformation exposes the Sg atom
of Cys215, which might enhance the accessibility of the cata-
lytic cysteine for reducing agents once nonstress conditions
are restored (112). Reducing agents such as GSH or DTT have
been shown to reduce the active site sulfenamide, reverse the
conformational changes, and fully restore the phosphatase
activity (112, 136). In contrast, however, in the presence of
excess H2O2, overoxidation of the active site cysteine to sul-
finic and sulfonic acid occurs. This process is irreversible and
causes permanent inactivation of the phosphatase. Because
cyclic sulfenamide formation has been found to be stable for
>5 h in 50mM H2O2 (112), it is thought that this oxidative thiol
modification functions as a protective mechanism to prevent
PTP1B against irreversible overoxidation (112, 136). A similar
protection against overoxidation via sulfenamide bond for-
mation was also shown for OhrR in Bacillus subtilis (73). In
addition to sulfenamide bond formation, glutathionylation of
the catalytic cysteine in PTP1B might also protect the enzyme
against overoxidation (13). So far, what different roles glu-
tathionylation and sulfenamide bond formation might play in
the protection of the catalytic cysteine remains unclear.
Salmeen et al. (113) suggest that the formation of a sulfena-
mide bond may be the first step in protection, followed by
glutathionylation, which can occur as the enzyme is being
reduced (Fig. 6).
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Overoxidation of PTP1B—More Than
a Dead-End Product?
A recently applied MS-based approach revealed the extent
of oxidative thiol modification of PTP1B both in vitro and
in vivo (79). This approach verified that only the active site
cysteine of PTP1B is the target of thiol oxidative modifica-
tions. Surprisingly, however, quantitative analysis of the
in vivo oxidation state of PTP1B in cancer cell lines that con-
tinuously produce ROS revealed that *40% of PTP1B mol-
ecules were irreversibly overoxidized. Between 25% and 50%
of all PTP1B molecules were found to be reversibly oxidized
to either sulfenic acid or sulfonamide, whereas only 10%–
15 % of cellular PTP1B was found in its reduced and active
form (79). These results indicated that the level of ROS in
these cell lines is sufficient to cause terminal oxidation of a
significant amount of PTP1B protein, despite the presence of
high levels of glutathione (51). Interestingly, overoxidation of
the active site cysteine in PTP1B appears to fully reverse the
conformational changes that accompany ROS-mediated sul-
fenamide formation (112, 136). It is therefore not surprising
that overoxidized PTP1B does not trigger the cellular ma-
chinery that is usually responsible for the rapid degradation
of oxidatively damaged proteins (79). It will now be inter-
esting to determine whether the overoxidized form of PTP1B
is indeed an end product that is destined for degradation or
whether it fulfills a yet to be determined alternative function
in the cell. The latter would be reminiscent of 2-Cys perox-
iredoxins, which are also highly susceptible to overoxidation
under high H2O2 concentration (144). Sulfinic acid formation
in 2-Cys peroxiredoxins leads to the inactivation of their
peroxidase activity, but at the same time, appears to convert
2-Cys peroxiredoxins into proteins with molecular chaperone
activity (57). This observation then raises the question as to
whether PTP1B-specific sulfinic acid reductases exist, which,
similar to sulfiredoxin in the case of overoxidized 2-Cys
peroxiredoxins (16), return PTP1B into its original redox and
functional state.
Other Redox-Regulated Signal Transduction
Cascades in Eukaryotes
Many physiological ligands such as hormones, growth
factors, and cytokines trigger intrinsic ROS production. ROS-
mediated regulation of protein tyrosine phosphatases (PTPs)
appears therefore to represent a general mechanism by which
ligands control PTP activity and therefore signal transduction
cascades. ROS- induced active site thiol modifications were
demonstrated for a variety of PTPs in different cell types and
included formation of disulfide bonds (e.g., LMW-PTPs,
Cdc25, and PTEN), cyclic sulfenamide (PTP1B and RPTPa)
(112, 148), and a potentially stabilized sulfenic acid (e.g., VHR
and LAR) (60, 85, 118). The active site cysteine of the tumor
suppressor PTEN (phosphatase with sequence homology to
tensin), for instance, which regulates the overall activity of
the PI3 kinase signaling pathway (132), is reversibly oxidized
by either RNS or H2O2. Oxidative inactivation of PTEN leads
to increased PtdIns(3,4,5)P3 (phosphatidylinositol (3,4,5)-tri-
sphosphate) levels, increased Akt–phosphorylation and ulti-
mately in cell growth (132). Reversible inactivation of MAP
kinase phosphatase 3 (MKP3) upon H2O2 treatment, on the
other hand, promotes TNFa-induced cell death (60). Inter-
estingly, MKP3 does not form a disulfide with a single
neighboring cysteine but can use multiple cysteines distrib-
uted in both the N-terminal and C-terminal domain to trap
the sulfenic acid of the active site cysteine (Cys293) as a dis-
ulfide (118). The availability of multiple redox active cyste-
ines, which has also been reported for other redox-sensitive
proteins (86), might represent a general mechanism to
prevent irreversible overoxidation of the active site sulfenic
acids.
It is interesting to note at this point that ROS generated by
distinct physiological stimuli often affect only a particular
subset of redox-sensitive PTPs. This specificity is well illus-
trated by the PDGF-induced specific oxidation of SHP-2 (85)
or the insulin-induced specific oxidation of PTP1B and TC-
PTP (84). Furthermore, in-gel phosphatase assays revealed
FIG. 5. Redox-mediated conformational changes in the catalytic site of PTP1B. Oxidation and sulfenamide bond for-
mation of PTP1B’s active site cysteine causes significant conformational changes in the catalytic site of PTP1B. Large
rearrangements of both pTyr loop (blue) and PTP loop (green) inhibit substrate binding and apparently protect the active
site Cys215 against irreversible overoxidation. Figures were made with PyMOL using the coordinates of reduced human
PTP1B protein (2BGE) and the sulfenamide species (1OEM) deposited in the Protein Data Bank. (For interpretation of the
references to color in this figure legend, the reader is referred to the web version of this article at www.liebertonline.
com=ars).
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that ROS generated by cancer cells selectively affect a subset
of cellular PTPs (79) and do not, as previously assumed, oxi-
dize all redox-sensitive PTPs that are expressed. As of now,
the reason behind this specificity is unknown. One explana-
tion might be a more localized generation of ROS upon en-
dogenous stimuli, which promotes oxidation of only those
PTPs that are close to the source of ROS production. Alter-
natively, however, metabolites and=or proteins specific for
individual signaling pathways might modulate the redox
sensitivity of a subset of phosphatases, thereby making them
more susceptible to ROS-mediated modification than others.
Similar observations have been made with protein kinase C,
whose redox regulation appears to be modulated by different
retinoids (53).
Concluding Remarks
Over the past 10 years, a vastly increasing number of pro-
teins have been identified that use thiol-based redox switches
to quickly regulate their function, activity, or structure in re-
sponse to changes in the redox homeostasis of the cell (3, 44,
48). As many of these redox-regulated proteins are central
players of metabolic and signal transduction pathways, this
strategy ensures that most cellular processes are under tight
FIG. 6. PTP1B—Redox regulation by cyclic sulfenamide formation. Under nonstress conditions, the active site cysteine
(Cys215) of tyrosine phosphatase PTP1B is reduced and PTP1B is active. (1) Upon exposure to oxidative stress conditions
(e.g., H2O2), Cys215 becomes oxidized to sulfenic acid, which inactivates the enzyme. (2a) Reaction of the active site sulfenic
acid with oxidized glutathione leads to S-glutathionylation (PTP1B-SSG). (2b) Alternatively, a nucleophilic attack of the
backbone nitrogen of Ser216 on the Sg-atom of Cys215 occurs, which results in the formation of a cyclic sulfenamide and the
release of water. Sulfenamide formation is promoted by the environment of the catalytic site, with His214 playing a pro-
minent role in polarizing the amide bond of Ser216. (2c) In the presence of excess H2O2, PTP1B’s sulfenic acid is overoxidized
to either sulfinic or sulfonic acid. (3) Active PTP1B can be either directly regenerated by reducing agents such as DTT in vitro
or (4) indirectly via the reaction of cyclic sulfenamide with GSH and the formation of PTP1B-SSG. (5) Reduced active PTP1B is
then formed by the subsequent reaction of PTP1B-SSG with the glutaredoxin (Grx) system.
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redox control. Here, we reviewed current knowledge about
three eukaryotic proteins with thiol-based redox switches,
Yap1p, GapDH, and PTP1B, and provided a short overview
of other redox-regulated proteins similarly involved in gene
expression, metabolic pathways or signal transduction. We
used these model proteins to illustrate the variety of
mechanisms by which cysteine thiols sense and respond to
reactive oxygen and nitrogen oxide species. However, as the
field expands, so does the knowledge that no singly unify-
ing concept can be used to characterize redox-regulated
proteins. While some redox-regulated proteins harbor only
one oxidative stress-sensitive cysteine (e.g., GapDH, PTP1B)
(13, 112, 120), others make use of cysteine clusters (e.g.,
Yap1b) (31, 69) or even redox-sensitive zinc centers (e.g.,
Hsp33, RsrA) (52, 56). The nature of the oxidative thiol
modifications depends largely on the type of oxidant as well
as on the environment of the cysteine within the protein.
Moreover, because most oxidative modifications affect cys-
teines in structurally or functionally important regions,
variations in the type of oxidative modifications often create
distinct conformational changes, which can result in differ-
ent functional states. Finally, whereas only a few proteins
harbor generally oxidative stress-sensitive cysteines (e.g.,
GapDH), most proteins have been found to be highly spe-
cific for distinct oxidative or nitrosative stressors (17); the
factors that are important for this specificity have yet to be
determined.
Oxidative and nitrosative stress is involved in many dis-
ease conditions, and numerous redox-regulated proteins have
been identified that use their redox sensitivity to protect cells
and organisms against these stress conditions. Despite the
tremendous increase in the number of redox-regulated pro-
teins identified, it is still unclear what makes cysteines par-
ticularly sensitive to specific oxidants in some proteins and
not in others. Our challenge for the future will be to obtain a
comprehensive view about what makes individual proteins
redox-sensitive. Can we predict, based on sequence and
structure similarities, the redox sensitivity of individual cys-
teines, and more importantly, a protein’s potential of being
redox- regulated? This capability would greatly facilitate ef-
forts to identify proteins that are potentially involved in the
oxidative stress protection of the cell. A number of global
proteomic techniques have been developed that allow the
identification of redox-regulated proteins in cells and or-
ganisms (76, 77, 149). With the use of highly quantitative
techniques such as the recently developed OxICAT method
(75), the thiol oxidation status of hundreds of different pro-
teins can be quantified in a single experiment. These tech-
niques, in combination with extensive biochemical and
structural studies, will have the potential to reveal novel
redox-regulated proteins. These studies will deepen our un-
derstanding of redox regulation and further confirm the im-
portance of oxidative thiol modifications as one of the key
posttranslational modifications in pro- and eukaryotic or-
ganisms.
Abbreviations
AP-1, activator protein-1; ARE, antioxidant response ele-
ment; ATF, activating transcription factor; bZIP, basic leucine
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nuclear export receptor; GAP, glyeraldehyde-3-phosphate;
GapDH, glyceraldehyde-3-phosphate dehydrogenase; Gpx,
glutathione peroxidase; Grx, glutaredoxin; GSH, glutathione
(reduced); GSNO, S-nitrosoglutathione; GSSG, glutathione
disulfide; Hsf-1, heat shock transcription factor 1; Hsp33, heat
shock protein 33; Keap1, Kelch-like ECH-associated protein-1;
MAPK, mitogen-activated protein kinase; MKP3, MAP kinase
phosphatase 3; NES, nuclear export signal; NF1, nuclear fac-
tor 1; NF-kB, nuclear factor kappa B; NLS, nuclear localization
signal; Nrf2, NF-E2-related factor-2; PDGF, platelet-derived
growth factor; PI3 kinase, phosphoinositide 3-kinase; PTEN,
phosphatase and tensin homolog; PTP, protein tyrosine
phosphatase; pTyr, phosphotyrosine; SOD, superoxide dis-
mutase; Spc1, suppressor of phosphatase 2C; TC-PTP, T-Cell
protein tyrosine phosphatase Tdh1, glyceraldehyde-3-
phosphate dehydrogenase, isozyme 1; TPI, triose phosphate
isomerase; Trx, thioredoxin; TrxR, thioredoxin reductase;
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